Description: How can generative artificial intelligence (AI) be leveraged to transform and modernize life insurance? Gain an overview of AI and some of their current use cases in the industry, including the latest trends in the market. Next, you will learn about the current challenges companies face, including costly underwriting procedures, customer acquisition and retention, and complicated application processes. Finally, explore how generative AI can help address these challenges, improve customer experience and help streamline processes to free up more time for higher-level business insights and other company initiatives.

Description: Focus on Accelerated Underwriting (AUW) in the life insurance industry, which is an expedited underwriting process that utilizes predictive models. Expect to address the challenges in designing the process, from modelling to performance monitoring. Additionally, you'll address risk management, particularly in mortality and proxy discrimination andhighlight the role an actuary can play in the AUW process, as well aswhat they should know to contribute effectively.

Description: In this wide-ranging session, expect updates on the work of the Individual Life Experience Committee and delve into some interesting recent research. You'll gain an update on recent findings from the Individual Life Experience Committee regarding individual life mortality experience.

Description: Electronic Health Records are here to stay. Take a deep dive into the world of electronic health records and how the industry is poised to utilize this new form of digital medical data to transform the way policies are underwritten and ultimately, transforming the client experience. Listen to industry experts speak about what they are doing to use this data most effectively and how this ultimately develops into ground-breaking solutions for the industry.

Description: Actuaries today have unique opportunities to analyze, understand and use data for strategic decision making. With nearly unlimited computing power and a broad spectrum of data sources at our fingertips, we are enabled to support our actuarial judgment with comprehensive findings backed up by deep data analyses.

Description: Are Accelerated Underwriting (AU) programs performing as expected? As mortality experience will (hopefully) be slow to emerge, it is pivotal that we look at alternative methods of monitoring early performance. From random hold outs, to post-issue APS's, and post-issue prescription profiles, explore popular monitoring techniques and lessons learned so far. Focus on confusion matrices that provide an early indication of mortality slippage relative to fluid-based underwriting decisions. Finally, explore statistical methods to determine what constitutes credibility and identify opportunities to think about mortality slippage more robustly.

Description: You’ve written the position papers, updated the models, and designed the required disclosures, but you may be wondering how to explain the results during interim financial reporting periods to company management as well as other stakeholders. This session will explore ways to adapt existing management reporting and offer ideas for new metrics. We will explore various methods for analyzing DAC amortization patterns, market risk benefit reserve patterns, and Liability for Future Benefits (LFPB) movements. In addition, this session will explore ways to integrate changes in LDTI with business planning and other broader business issues such as product pricing considerations and reinsurance strategy.

Description: Human longevity is one of the great success stories of the past century, and there is growing consensus that there are further gains to come. What will these future gains look like, where will they come from and how likely are they to happen. Furthermore, how do we as actuaries deal with the uncertainty when trying to predict future long-term mortality improvements more than 20 years into the future. This is one of the most important assumptions on the balance sheet that insurers and reinsurers make, so it is important to have a strong perspective on it. Our presentation will give attendees a view into some of the core components of how to assess long-term mortality improvements by looking at the cyclical nature across different countries of life expectancy. It will also deep dive into the different drivers of life expectancy over the past cycle driven largely by improved diagnosis and treatment of cardiovascular disease (CVD) and cessation of smoking, which ended in about 2010. It will then discuss how population mortality improvement has slowed and plateaued in many major countries.